TART - Troglitazone Atherosclerosis Regression Trial
Status:
Completed
Trial end date:
2000-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if troglitazone reduces the progression of early
preintrusive carotid atherosclerosis in insulin-requiring diabetes patients.